BDBM264471 2-(thiazol-2-yl)-6-(4-(4-(trifluoromethyl)phenoxy)phenyl)-3,4-dihydro-2H-benzo[e][1,2]thiazine 1,1-dioxide::US9714252, 7

SMILES FC(F)(F)c1ccc(Oc2ccc(cc2)-c2ccc3c(CCN(c4nccs4)S3(=O)=O)c2)cc1

InChI Key InChIKey=AZGWIGGQLCXVDW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 264471   

TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM264471(2-(thiazol-2-yl)-6-(4-(4-(trifluoromethyl)phenoxy)...)
Affinity DataIC50:  7.09E+3nMAssay Description:Representative Compounds of the Invention have been tested in the FLIPR, FLIPRTETRA, and/or electrophysiology (EP) assays for sodium channel blocking...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent